A mystery man or woman in Victoria who tested positive for COVID-19 twice is now the subject of intense interest among virus researchers around Australia. Victorian Premier Dan Andrews’ confirmation that medical experts are treating the case as the nation’s first ever reinfection will likely spark international attention. Reports of reinfection with SARS-CoV-2 are rare… Read More »
“Those who are vaccine hesitant have had their hesitancy enhanced by a variety of things that are happening right now, particularly the unfortunate mix of science and politics,” Collins said at an event hosted by the National Academies of Sciences, Engineering and Medicine. A recent poll from the Kaiser Family Foundation found that more than… Read More »
Two German biotechs, BioNTech and CureVac, have been at the cutting edge of the hunt for a COVID-19 vaccine—a time-consuming and costly process. In order to get both over the finish line, the German government is making a big investment in both candidates’ development. The German government has awarded the mRNA-based vaccine makers a combined… Read More »
According to a study carried out by Lloyds Pharmacy 46% of Irish adults said they are planning on getting the flu vaccine this year. Research shows, 74 per cent of adults claim that the COVID-19 pandemic has made them more aware of the importance of being vaccinated against viruses. However, 46 per cent of adults… Read More »
A view of Moderna headquarters on May 08, 2020 in Cambridge, Massachusetts. Moderna was given FDA approval to continue to phase 2 of Coronavirus (COVID-19) vaccine trials with 600 participants. (Photo by Maddie Meyer/Getty Images) Moderna Inc., a biotech company that develops pharmaceuticals, received $ 472 million award from the federal Biomedical Advanced Research and… Read More »